The University of Arizona
Institutional Knowledge Map (KMap)
Picture of Adam Raikes

Adam Raikes

Project Manager, Imaging

UAHS Brain Science
Map Page
10+ Collaborators
$338.3K / $1.6M Funding
80+ Publications

Research Area

neuroscience, sleep, brain injury, concussion, brain imaging, alzheimer's disease, cognitive function, light therapy, ptsd, aging, mental health, neuroimaging, daytime sleepiness, genetics, neurology, traumatic brain injury, concussion assessment, electrodermal activity, gender differences, sleep deprivation, resilience, brain structure, sleepiness, behavior, translational research

    Chart
    Bar chart with 12 bars.
    The chart has 1 X axis displaying Year.
    The chart has 1 Y axis displaying values. Data ranges from 1 to 21.
    End of interactive chart.
    Recent

    Impact of humanized APOE on brain volumetrics and white matter microstructure within a mouse model for Alzheimer’s Disease

    2024

    Associations Between Sex‐and APOE‐Specific Transcriptomic Signatures in Alzheimer's Disease and Imaging‐Derived Phenotypes: An AZ‐ADRC‐Research Education Scholars Team Science …

    2024
    alzheimer's disease, apoe

    The Inter-Personal Affect Regulation Test IPART) Development and Validation of a Performance-Based Assessment of the Ability to Improve the Emotions of Others

    2024

    Schlaf in sozialer Kognition und Urteilsvermögen

    2024
    sleep, social cognition, judgment, mental processes, behavior

    Automated quality control of small animal MR neuroimaging data

    2024
    neuroimaging, quality control, mr imaging

    Endocrinological aging drives alterations in white matter architecture: Evidence from a humanized APOE risk model of Alzheimer’s disease

    2024
    neuroscience, aging, alzheimer's, endocrinology, white matter

    Loss of Fatty Acid Degradation by Astrocytic Mitochondria as a Mechanism of Neuroinflammation and Neurodegeneration

    2023

    Development of a selective estrogen β‐receptor phytoestrogen formulation–PhytoSERM–for the reduction of Alzheimer’s risk and relief of menopausal symptoms in women: a phase 2 …

    2023
    alzheimer's, menopause, receptor, formulation

    Allopregnanolone as a Regenerative Therapeutic for Alzheimer’s Disease AD) A phase 2 proof-of-concept clinical trial using hippocampal volume as a surrogate endpoint P8-6.008)

    2023
    alzheimer's disease, regenerative therapy, allopregnanolone, hippocampal volume

    Correlational analysis of plasma metabolome and brain imaging in a humanized APOE mouse model

    2023
    metabolomics, neuroimaging, genetics, animal model, correlation analysis

    Page 1 of 3
    Adam Raikes | KMap Profile - Institutional Knowledge Map (KMap)